ARTICLE | Company News
Harbor BioSciences, China National Pharmaceutical Group Corp. deal
January 24, 2011 8:00 AM UTC
Harbor granted China National Pharmaceutical Group's China State Institute of Pharmaceutical Industry (CIPI) subsidiary exclusive rights to develop and commercialize HE2000, Apoptone ( HE3235) and ...